ONC Q2 2020 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q2 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$66M-73.0% YoY

Gross Profit

$51M78.2% margin

Operating Income

-$359M-546.8% margin

Net Income

-$335M-510.7% margin

EPS (Diluted)

$-4.29

QoQ Revenue Growth

+26.1%

Cash Flow

Operating Cash Flow

-$263M

Free Cash Flow

-$296M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$1.4B

Stockholders' Equity

$2.5B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$243M	-73.0%
Gross Profit	$51M	-$3M	+1677.9%
Operating Income	-$359M	-$86M	-318.1%
Net Income	-$335M	-$86M	-291.7%